252 related articles for article (PubMed ID: 8821628)
21. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
Musgrave BL; Watson CL; Hoskin DW
J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
[TBL] [Abstract][Full Text] [Related]
22. Specific inhibition of T lymphocyte coactivation by triggering integrin beta 1 reveals convergence of beta 1, beta 2, and beta 7 signaling pathways.
Woodside DG; Teague TK; McIntyre BW
J Immunol; 1996 Jul; 157(2):700-6. PubMed ID: 8752919
[TBL] [Abstract][Full Text] [Related]
23. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
24. Anti-CD48 (murine CD2 ligand) mAbs suppress cell mediated immunity in vivo.
Chavin KD; Qin L; Lin J; Woodward J; Baliga P; Kato K; Yagita H; Bromberg JS
Int Immunol; 1994 May; 6(5):701-9. PubMed ID: 7521667
[TBL] [Abstract][Full Text] [Related]
25. CD49d expression and function on allergen-stimulated T cells from blood and airway.
Pacheco KA; Tarkowski M; Klemm J; Rosenwasser LJ
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):286-93. PubMed ID: 9476917
[TBL] [Abstract][Full Text] [Related]
26. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
27. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.
Kato K; Koyanagi M; Okada H; Takanashi T; Wong YW; Williams AF; Okumura K; Yagita H
J Exp Med; 1992 Nov; 176(5):1241-9. PubMed ID: 1383383
[TBL] [Abstract][Full Text] [Related]
28. Defective cytokine expression but adult-type T-cell receptor, CD8, and p56lck modulation in CD3- or CD2-activated T cells from neonates.
Pirenne-Ansart H; Paillard F; De Groote D; Eljaafari A; Le Gac S; Blot P; Franchimont P; Vaquero C; Sterkers G
Pediatr Res; 1995 Jan; 37(1):64-9. PubMed ID: 7700735
[TBL] [Abstract][Full Text] [Related]
29. Activation of T cells through a T cell-specific epitope of CD45.
Torimoto Y; Dang NH; Streuli M; Rothstein DM; Saito H; Schlossman SF; Morimoto C
Cell Immunol; 1992 Nov; 145(1):111-29. PubMed ID: 1384991
[TBL] [Abstract][Full Text] [Related]
30. Regulation of T cell proliferation by anti-CD49d and anti-CD29 monoclonal antibodies.
Bednarczyk JL; Teague TK; Wygant JN; Davis LS; Lipsky PE; McIntyre BW
J Leukoc Biol; 1992 Oct; 52(4):456-62. PubMed ID: 1383369
[TBL] [Abstract][Full Text] [Related]
31. Differential immunomodulation by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell activation: dependence upon the individual anti-CD3 monoclonal antibody used for activation.
Stohl W; Posnett DN; Chiorazzi N
Cell Immunol; 1988 Oct; 116(1):73-85. PubMed ID: 2458845
[TBL] [Abstract][Full Text] [Related]
32. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.
Plain KM; Chen J; Merten S; He XY; Hall BM
Transplantation; 1999 Feb; 67(4):605-13. PubMed ID: 10071035
[TBL] [Abstract][Full Text] [Related]
33. Specific regulation of VLA-4 and alpha 4 beta 7 integrin expression on human activated T lymphocytes.
Hernández-Caselles T; Martínez-Esparza M; Lazarovits AI; Aparicio P
J Immunol; 1996 May; 156(10):3668-77. PubMed ID: 8621901
[TBL] [Abstract][Full Text] [Related]
34. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies.
Chavin KD; Lau HT; Bromberg JS
Transplantation; 1992 Aug; 54(2):286-91. PubMed ID: 1353913
[TBL] [Abstract][Full Text] [Related]
35. Differential activation through the TCR-CD3 complex affects the requirement for costimulation of human T cells.
Kawaguchi M; Eckels DD
Hum Immunol; 1995 Jun; 43(2):136-48. PubMed ID: 7591873
[TBL] [Abstract][Full Text] [Related]
36. Comparison of CD3 and CD2 activation pathways in T cells from young and elderly adults.
Song LJ; Nagel JE; Chrest FJ; Collins GD; Adler WH
Aging (Milano); 1992 Dec; 4(4):307-15. PubMed ID: 1363463
[TBL] [Abstract][Full Text] [Related]
37. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
[TBL] [Abstract][Full Text] [Related]
38. Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29).
Kamata T; Puzon W; Takada Y
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):945-51. PubMed ID: 7531439
[TBL] [Abstract][Full Text] [Related]
39. Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production.
Sido B; Dengler TJ; Otto G; Zimmermann R; Müller P; Meuer SC
Eur J Immunol; 1998 Apr; 28(4):1347-57. PubMed ID: 9565375
[TBL] [Abstract][Full Text] [Related]
40. Anti-T11.1 and -T11.2 monoclonal antibodies play a different role in CD2-mediated signal transduction.
Bagnasco M; Franco MD; Lopez M; Nunes J; Lipcey C; Mawas C; Salamero J; Olive D
Hum Immunol; 1993 Nov; 38(3):172-8. PubMed ID: 7508902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
